• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1992 - 2000年中国启东的癌症生存率

Cancer survival in Qidong, China, 1992-2000.

作者信息

Chen J G, Zhu J, Zhang Y H, Lu J H

机构信息

Qidong Cancer Registry, Department of Epidemiology, Qidong Liver Cancer Institute, Jiangsu, China.

出版信息

IARC Sci Publ. 2011(162):43-53.

PMID:21675405
Abstract

The Qidong cancer registry was established in 1972, and registration of cases is done by active and passive methods. The registry contributed data on 33 cancer sites or types registered during 1992-2000 for this survival study. Data on 22 cancers registered during 1972-2000 were utilized to elicit the survival trend by period and cohort approaches. Follow-up was done by a mixture of active and passive methods, with median follow-up ranging from 2-25 months. The proportion of cases with histologically verified cancer diagnosis ranged from 9-100%, and 87-100% of total registered cases were included for survival analysis. The top-ranking cancers on 5-year age-standardized relative survival (%) were thyroid (78%), breast (58%), corpus uteri (54%), larynx (51%) and urinary bladder (42%). The corresponding survival rates for common cancers were liver (6%), lung (7%) and stomach (18%). The 5-year relative survival by age group fluctuated and showed no distinct pattern or trend. The comparison of 5-year relative survival trend by cohort and period approaches revealed that period survival closely predicted the survival experience of cancer cases diagnosed in that period for most cancers.

摘要

启东癌症登记处成立于1972年,通过主动和被动方式进行病例登记。该登记处为本生存研究提供了1992 - 2000年期间登记的33种癌症部位或类型的数据。利用1972 - 2000年期间登记的22种癌症的数据,通过时期和队列方法得出生存趋势。随访采用主动和被动相结合的方式,中位随访时间为2 - 25个月。经组织学证实癌症诊断的病例比例为9% - 100%,纳入生存分析的登记病例总数比例为87% - 100%。5年年龄标准化相对生存率(%)排名靠前的癌症为甲状腺癌(78%)、乳腺癌(58%)、子宫体癌(54%)、喉癌(51%)和膀胱癌(42%)。常见癌症的相应生存率为肝癌(6%)、肺癌(7%)和胃癌(18%)。按年龄组划分的5年相对生存率波动,未显示出明显的模式或趋势。通过队列和时期方法对5年相对生存趋势的比较表明,对于大多数癌症,时期生存密切预测了该时期诊断的癌症病例的生存经历。

相似文献

1
Cancer survival in Qidong, China, 1992-2000.1992 - 2000年中国启东的癌症生存率
IARC Sci Publ. 2011(162):43-53.
2
Cancer survival in Tianjin, China, 1991-1999.1991 - 1999年中国天津的癌症生存率
IARC Sci Publ. 2011(162):69-84.
3
Cancer survival in Shanghai, China, 1992-1995.1992 - 1995年中国上海的癌症生存率
IARC Sci Publ. 2011(162):55-68.
4
Cancer survival in Singapore, 1993-1997.1993 - 1997年新加坡的癌症生存率
IARC Sci Publ. 2011(162):183-98.
5
Cancer survival in Hong Kong SAR, China, 1996-2001.1996 - 2001年中国香港特别行政区的癌症生存率。
IARC Sci Publ. 2011(162):33-41.
6
Cancer survival in Incheon, Republic of Korea, 1997-2001.1997 - 2001年韩国仁川的癌症生存率
IARC Sci Publ. 2011(162):163-9.
7
Cancer survival in Seoul, Republic of Korea, 1993-1997.1993 - 1997年韩国首尔的癌症生存率
IARC Sci Publ. 2011(162):171-8.
8
Cancer survival in Busan, Republic of Korea, 1996-2001.1996 - 2001年韩国釜山的癌症生存率
IARC Sci Publ. 2011(162):155-62.
9
Cancer survival in Cuba, 1994-1995.1994 - 1995年古巴的癌症生存率
IARC Sci Publ. 2011(162):89-95.
10
Cancer survival in Karunagappally, India, 1991-1997.1991 - 1997年印度卡鲁纳加帕利的癌症生存率
IARC Sci Publ. 2011(162):125-32.

引用本文的文献

1
Five-year survival rate of kidney cancer (localized renal cell carcinoma) in the Asia: A systematic review and meta-analysis.亚洲肾癌(局限性肾细胞癌)的五年生存率:一项系统评价和荟萃分析。
Medicine (Baltimore). 2025 Aug 22;104(34):e43867. doi: 10.1097/MD.0000000000043867.
2
Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018).伊朗库尔德斯坦省前列腺癌的总生存率和预后因素:一项基于人群的研究(2011-2018 年)。
BMC Cancer. 2021 Dec 8;21(1):1314. doi: 10.1186/s12885-021-09078-8.
3
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.
亚洲国家肝细胞癌的生存率:一项系统评价与荟萃分析。
EXCLI J. 2020 Jan 13;19:108-130. doi: 10.17179/excli2019-1842. eCollection 2020.
4
Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis.亚洲国家前列腺癌的生存率:一项系统评价与荟萃分析。
Ann Glob Health. 2020 Jan 2;86(1):2. doi: 10.5334/aogh.2607.
5
Survival of Cancer Patients in Northeast China: Analysis of Sampled Cancers from Population-Based Cancer Registries.中国东北地区癌症患者的生存状况:基于人群癌症登记处抽样癌症的分析。
Cancer Res Treat. 2017 Oct;49(4):1106-1113. doi: 10.4143/crt.2016.613. Epub 2017 Feb 2.
6
Quality of life in women with cervical precursor lesions and cancer: a prospective, 6-month, hospital-based study in China.中国宫颈前驱病变和癌症女性的生活质量:一项基于医院的前瞻性6个月研究。
Chin J Cancer. 2014 Jul;33(7):339-45. doi: 10.5732/cjc.013.10139. Epub 2014 Apr 4.
7
Changing rates for liver and lung cancers in Qidong, China.中国启东肝癌和肺癌发病率的变化情况。
Chem Res Toxicol. 2014 Jan 21;27(1):3-6. doi: 10.1021/tx400313j. Epub 2013 Nov 20.
8
Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China.降低黄曲霉毒素暴露可预示中国肝癌高发区肝癌死亡率的下降。
Cancer Prev Res (Phila). 2013 Oct;6(10):1038-45. doi: 10.1158/1940-6207.CAPR-13-0168. Epub 2013 Aug 20.
9
A multisource approach to improving epidemiologic estimates: application to global B-cell malignancies.一种用于改进流行病学估计的多源方法:应用于全球B细胞恶性肿瘤
ISRN Oncol. 2012;2012:129713. doi: 10.5402/2012/129713. Epub 2012 Dec 31.
10
Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients.RASSF2的异位表达及其对胃腺癌患者的预后作用。
Exp Ther Med. 2012 Mar;3(3):391-396. doi: 10.3892/etm.2011.440. Epub 2011 Dec 28.